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Previewscomponents such as APC. It is becoming
clear, however, that a wide range of
cancers activate Wnt signaling by epige-
neticdownregulationof secretedWnt inhib-
itors such as Dkk1, WIF1, and members of
the secreted Frizzled-related family (Ying
and Tao, 2009). Especially in these cases,
CKId/3 inhibitors such as TAK-715 and
AMG-548 may prove to be therapeutically
important.410 Chemistry & Biology 18, April 22, 2011 ªREFERENCES
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An audacious bet on transforming histone H4 into a real-time sensor probe has been won by the group of
Minoru Yoshida, who designed the first FRET probes capable of signaling the occurrence of dynamic site-
specific acetylations in live cells.Analyzing and understanding the func-
tional significance of genome signposting
by covalent modifications of DNA and
histones constitutes a real challenge in
modern biology. An important feature of
these signs is their dynamic nature, which
correlates with their potential to act as
a support for the so-called heritable
epigenetic information. The precise vision
of these dynamic alterations of DNA and
histones is critical to fully understanding
the epigenome and its regulatory circuits.
The advent of live cell imaging and
fluorescent probes is now allowing the
design of experimental approaches to
achieve this goal. Our increasing knowl-
edge of cellular machineries capable
of recognizing DNA methylation and
specific histone posttranslational modifi-
cations (PTM) has opened the way for
the design of fluorescent protein-based
probes bearing specific binding domains
of the corresponding factors and antibody
fragments capable of recognizing specific
modifications. Several FRET probes were
also conceived using a combination of
a histone PTM-binding element and ahistone fragment capable of receiving
the PTM (Kimura et al., 2010). These
approaches had two major limitations.
The first was that the probes needed to
access their targets to generate meaning-
ful signals, therefore creating a depen-
dency on the state of chromatin and site
accessibility. The second limitation was
the inability of fusions comprising histone
fragments to integrate chromatin, making
them insensitive to chromatin-dependent
events.
The design of a probe capable of being
assembled into chromatin (in other words,
a histone-sensor of PTMs) therefore
appeared as an elegant way to circum-
vent these problems. However, feasibility
issues hit the attractiveness of the idea
and could have stopped many from
trying. The group of Minoru Yoshida
started the adventure by using a full-
length histone H4 as a building basis for
a histone-probe molecule. The aim was
to develop a sensor of H4 acetylation by
using an already characterized bromodo-
main-containing protein, fused to the
N-terminal of the histone and separatedfrom it by a flexible linker peptide. Two
GFP-derived proteins (Venus and CFP)
were also fused on either side of the re-
sulting protein in order to generate a full-
length probe susceptible of reporting a
FRET signal after an acetylation-depen-
dent conformation change (Sasaki et al.,
2009; Ito et al., 2011).
Outstandingly, this fusion protein is
recognized as a regular histone H4 by the
cellular chromatin assembly machinery
and is incorporated into chromatin, there-
fore giving the unprecedented power of
sensing the occurrence of an acetylation
event from the ‘‘inside’’ of a chromatin
fiber. The first probe, named Histac,
contained Brdt, a testis-specific double
bromodomain protein (Pivot-Pajot et al.,
2003) as the acetyl-recognition module.
One of the first pieces of information
revealed by the probe was the identity of
the acetyl-acceptor sites, recognized by
Brdt in living cells, as being lysine 5 and
8 (K5 and K8) on histone H4. The data
also indicated the requirement of the
simultaneous acetylation of H4K5 and
H4K8 for Brdt to bind (Sasaki et al.,
Figure 1. Generation of Chromatin Sensors Capable of Reporting the Occurrence of Site-Specific Histone H4 Acetylations
The expression of histone H4 bearing specific acetylated lysine-recognition modules, bromodomains of Brdt or Brd2, allows its assembly into chromatin. The
resulting FRET probes not only allow demonstration of the dynamics of histone H4 acetylation at these specific sites as a function of different events, i.e., cell
cycle, but also can serve as a reporter to measure the impact of particular HAT or HDAC on these acetylations. These probes also provide excellent readouts
for the discovery of a wide range of small molecule effectors of enzymatic activities or bromodomains. Additionally, a panel of experiments could be designed to
test the impact of particular cellular and viral regulatory factors on site-specific histone acetylation, using Histac/Histac-K12 as a reporter.
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Previews2009). Interestingly, a parallel structural
work based on the crystal structure of
Brdt’s first bromodomain, BD1, uncov-
ered the exact same property of double
acetyl-lysine binding (Morinie`re et al.,
2009) and therefore unquestionably sup-
ported the performance and the reliability
of the designed probe. Reciprocally, this
approach also elegantly showed that the
crystal-based structural data are valid in
a living cell, in the heart of a dynamic
chromatin. The specificity of Brdt for
H4K5ac-H4K8ac also made the probe
a unique and therefore precious sensor
of the occurrence of H4 hyperacetylation
in living cells. Indeed, since simultaneous
acetylation of H4 K5 and K8 is a signature
of hyperacetylated H4 (Sasaki et al.,
2009), Histac is a perfect probe to eval-
uate the efficacy of histone-deacetylase
inhibitors (HDACi) bymeasuring the ability
of these molecules to induce a full acety-
lation of histone H4. Hence, the measure-
ment of HDAC inhibition by various
types of inhibitors in living cell with an
unprecedented sensitivity is the second
outstanding application of Histac. Finally,
Histac allowed a real-time visualization of
histone hyperacetylation during mitosisrevealing a dramatic loss of histone H4
hyperacetylation after the onset of chro-
mosome compaction (Sasaki et al., 2009).
Following the same principle, Yoshida’s
group developed another related probe
using Brd2 (Kanno et al., 2004) as the
acetyl-reading module. This new probe
revealed itself as being very complemen-
tary to Histac because it specifically
signals the occurrence of acetylation on
H4K12, hence named Histac-K12 (Ito
et al., 2011). The two probes together
therefore allow a real-time visualization
of the occurrence of acetylation on
different lysines of H4: K5-K8 and K12.
The use of Histac-K12 showed that,
in contrast to H4K5-8, acetylation of
H4K12 is not affected by chromosome
compaction during mitosis. Additionally,
although Histac-K12 allowed evaluation
of the acetylation response to HDACi
treatments with the same sensitivity as
Histac, this probe revealed an unex-
pected stability of H4K12 acetylation
after the removal of several unrelated
HDACis. The use of Histac to measure
the stability of H4K5acK8ac under the
same experimental conditions will tell if
acetylation on these two residues is alsoChemistry & Biology 18, April 22, 2011unexpectedly stable. This may lead to
the discovery of yet unknown mecha-
nisms controlling bromodomain-depen-
dent stability of specific acetylation marks
or reveal an unexpected retention of some
of the HDAC inhibitors in the treated cells.
In addition to HDACs, these probes
also offer a highly sensitive readout for
a new class of small inhibitory molecules:
bromodomain inhibitors. Yoshida and
colleagues used Histac-K12 to demon-
strate the use of this probe in evaluating
the efficacy of a new bromodomain inhib-
itor named BIC1 (Ito et al., 2011). Histac/
Histac-K12 would of course now provide
the community with excellent probes for
the identification and characterization of
new bromodomain inhibitors, whichmight
constitute a new category of epigenetic
drugs (Filippakopoulos et al., 2010).
Finally, although not yet exploited, these
probes open the way for evaluating
the contribution of specific HDACs and
histone acetyltransferases (HATs,) as
well as their cellular and viral regulators,
in site-specific histone acetylation in living
cells by using either specific interfering
small RNAs or specific small molecule
inhibitors (Figure 1).ª2011 Elsevier Ltd All rights reserved 411
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PreviewsOne of the remarkable aspects of the
work by Yoshida’s laboratory is the
demonstration that an individual histone
could be transformed into a sensor-probe
without losing its ability to be incorpo-
rated into chromatin. The generation of
Histac/Histac-K12 showed that a histone
can in fact accommodate large nonhis-
tone segments and still be recognized
by the cellular chromatin assembly
machinery. This demonstration is now
paving the way for the generation of
a multitude of histone-based probes
bearing various histone PTM-recognizing
modules. These probes are expected to412 Chemistry & Biology 18, April 22, 2011 ªtremendously accelerate our under-
standing of epigenetics and, among
other things, provide highly sensitive
readouts for the discovery of new epige-
netic drugs.REFERENCES
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